MetLife Investment Management LLC lifted its stake in shares of National Health Investors, Inc. (NYSE:NHI - Free Report) by 706.6% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 213,730 shares of the real estate investment trust's stock after acquiring an additional 187,233 shares during the quarter. MetLife Investment Management LLC owned approximately 0.46% of National Health Investors worth $15,786,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds also recently made changes to their positions in the stock. Dimensional Fund Advisors LP raised its position in shares of National Health Investors by 3.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 634,430 shares of the real estate investment trust's stock worth $43,966,000 after acquiring an additional 20,631 shares during the last quarter. Northern Trust Corp grew its stake in National Health Investors by 19.9% during the fourth quarter. Northern Trust Corp now owns 613,791 shares of the real estate investment trust's stock worth $42,536,000 after purchasing an additional 101,808 shares during the period. Bank of New York Mellon Corp grew its stake in National Health Investors by 5.6% during the first quarter. Bank of New York Mellon Corp now owns 588,871 shares of the real estate investment trust's stock worth $43,494,000 after purchasing an additional 31,451 shares during the period. Centersquare Investment Management LLC grew its stake in National Health Investors by 25.7% during the first quarter. Centersquare Investment Management LLC now owns 495,971 shares of the real estate investment trust's stock worth $36,632,000 after purchasing an additional 101,538 shares during the period. Finally, Millennium Management LLC grew its stake in National Health Investors by 1,967.0% during the fourth quarter. Millennium Management LLC now owns 488,353 shares of the real estate investment trust's stock worth $33,843,000 after purchasing an additional 464,727 shares during the period. 62.51% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
NHI has been the subject of several recent analyst reports. Truist Financial raised their target price on National Health Investors from $77.00 to $81.00 and gave the stock a "buy" rating in a research note on Friday, August 15th. Wells Fargo & Company raised their target price on National Health Investors from $76.00 to $80.00 and gave the stock an "equal weight" rating in a research note on Wednesday. KeyCorp raised National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 target price for the company in a research note on Thursday, July 10th. Finally, Wedbush raised National Health Investors to a "strong-buy" rating in a research note on Wednesday, July 2nd. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus price target of $84.20.
View Our Latest Stock Analysis on National Health Investors
National Health Investors Stock Up 0.9%
National Health Investors stock traded up $0.68 during mid-day trading on Friday, reaching $78.33. The stock had a trading volume of 193,835 shares, compared to its average volume of 223,797. The company has a debt-to-equity ratio of 0.75, a quick ratio of 10.91 and a current ratio of 10.91. National Health Investors, Inc. has a fifty-two week low of $65.13 and a fifty-two week high of $86.13. The stock's 50-day simple moving average is $72.74 and its 200-day simple moving average is $72.90. The firm has a market capitalization of $3.72 billion, a PE ratio of 25.02, a price-to-earnings-growth ratio of 3.36 and a beta of 0.73.
National Health Investors (NYSE:NHI - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The real estate investment trust reported $1.22 EPS for the quarter, beating analysts' consensus estimates of $1.16 by $0.06. National Health Investors had a return on equity of 10.32% and a net margin of 40.97%.The firm had revenue of $70.27 million during the quarter, compared to analysts' expectations of $86.46 million. During the same quarter last year, the firm posted $1.18 earnings per share. The company's revenue for the quarter was up 6.7% compared to the same quarter last year. On average, sell-side analysts forecast that National Health Investors, Inc. will post 4.41 EPS for the current fiscal year.
National Health Investors Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be given a dividend of $0.92 per share. The ex-dividend date of this dividend is Tuesday, September 30th. This is a positive change from National Health Investors's previous quarterly dividend of $0.90. This represents a $3.68 annualized dividend and a dividend yield of 4.7%. National Health Investors's payout ratio is presently 115.02%.
National Health Investors Profile
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Featured Stories

Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.